Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Heron Therapeutics Inc (NASDAQ:HRTX)

16.65
Delayed Data
As of Jul 22
 +0.46 / +2.84%
Today’s Change
15.22
Today|||52-Week Range
42.25
-37.64%
Year-to-Date
No recent news for Heron Therapeutics Inc.

Today’s Trading

Previous close16.19
Today’s open16.16
Day’s range15.92 - 16.74
Volume407,676
Average volume (3 months)545,984
Market cap$610.4M
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-2.79%
Earnings growth (this year)-21.65%
Earnings growth (next 5 years)+72.27%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.09

Competitors

 Today’s
change
Today’s
% change
DVAXDynavax Technologies...+0.01+0.07%
ZIOPZIOPHARM Oncology In...-0.11-2.39%
EPZMEpizyme Inc-0.10-0.99%
PDLIPDL BioPharma Inc+0.01+0.28%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.94
Annual revenue (last year)$0.00
Annual profit (last year)-$97.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
Redwood City, California

Forecasts

Partner Offers

Search for Jobs